Medicare started covering obesity drugs. Walmart and CVS decided they should help seniors figure out how to get them. Two companies famous for understaffing their pharmacy counters are now the trusted guides through the Byzantine nightmare of Medicare Part D coverage.
The same corporation that can't keep more than one register open during peak hours wants to walk your grandmother through prior authorization forms.
CVS will do this between filling prescriptions, selling candy bars three feet from the insulin, and asking if you want to sign up for a rewards card that saves you eight cents on paper towels.
Walmart's strategy involves stationing someone near the pharmacy who may or may not have health insurance themselves. They'll explain coverage gaps while standing under fluorescent lights that haven't been replaced since 2019. The floor will be sticky. There will be a crying child.
Medicare covering obesity drugs is new. The market for companies pretending they care about your health is not. These retailers saw seniors trying to navigate formularies and step therapy requirements and thought: perfect, another service we can monetize while appearing helpful.
Patients get to stand in line behind someone arguing about a coupon that expired in 2023. Then they'll discuss their BMI and cardiovascular risk factors with a person wearing a vest.
The technical setup here is flawless. Retail traders will see "Walmart" and "healthcare" in the same headline and assume it's bullish. They'll buy calls without reading past the summary. They won't consider that helping seniors navigate insurance paperwork generates exactly zero revenue.
But the chart doesn't care about your grandpa's Ozempic prior auth getting denied three times. Support holds at the level where it always holds: wherever large institutions decide they're done selling to you.
Photo by on Unsplash
Leave a Comment